UK Markets open in 3 hrs 14 mins
NIKKEI 225
27,085.97 +93.76 (+0.35%) HANG SENG
17,976.26 +896.75 (+5.25%) CRUDE OIL
86.19 -0.33 (-0.38%) GOLD FUTURES
1,728.30 -2.20 (-0.13%) DOW
30,316.32 +825.43 (+2.80%) BTC-GBP
17,663.54 +453.57 (+2.64%)
Innate Pharma S.A. (IPHA)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | N/A |
| Enterprise value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | N/A |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | 0.17 |
| 52-week change 3 | -64.10% |
| S&P500 52-week change 3 | -13.12% |
| 52-week high 3 | 6.5000 |
| 52-week low 3 | 1.9200 |
| 50-day moving average 3 | 2.6175 |
| 200-day moving average 3 | 3.1771 |
Share statistics
| Avg vol (3-month) 3 | 8.33k |
| Avg vol (10-day) 3 | 18.27k |
| Shares outstanding 5 | 79.89M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 51.89M |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 1.20% |
| Shares short (14 Sept 2022) 4 | 111.91k |
| Short ratio (14 Sept 2022) 4 | 31.22 |
| Short % of float (14 Sept 2022) 4 | N/A |
| Short % of shares outstanding (14 Sept 2022) 4 | 0.14% |
| Shares short (prior month 14 Aug 2022) 4 | 109.24k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | N/A |
| Trailing annual dividend yield 3 | N/A |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Currency in EUR.Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Jun 2022 |
Profitability
| Profit margin | -39.99% |
| Operating margin (ttm) | -32.98% |
Management effectiveness
| Return on assets (ttm) | -4.30% |
| Return on equity (ttm) | -17.31% |
Income statement
| Revenue (ttm) | 56.98M |
| Revenue per share (ttm) | 0.71 |
| Quarterly revenue growth (yoy) | 242.50% |
| Gross profit (ttm) | -22.3M |
| EBITDA | -14.33M |
| Net income avi to common (ttm) | -21.63M |
| Diluted EPS (ttm) | -0.6940 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 123.35M |
| Total cash per share (mrq) | 1.54 |
| Total debt (mrq) | 43.37M |
| Total debt/equity (mrq) | 37.28 |
| Current ratio (mrq) | 2.34 |
| Book value per share (mrq) | 1.46 |
Cash flow statement
| Operating cash flow (ttm) | -26.08M |
| Levered free cash flow (ttm) | -40.59M |
© 2022 Yahoo. All rights reserved.
